Lymphomas and Leukemias

Leukemia and lymphoma are hematologic neoplasms that affect members of all age groups. Each year, over 140,000 people in the US are diagnosed with a hematologic malignancy of some kind. With constant advancement of treatment options, the importance of accurate diagnosis and detection of lymphomas and leukemias becomes more and more relevant to the survival of the patient, and immunohistochemistry has served as a key auxiliary test in determining these diagnoses. This presentation covers many of the basic science, facts, and statistics of hematologic malignancies, as well as the utility of immunohistochemical testing with markers such as CD20, PAX-5, CD61, CD71, Cyclin D1, and SOX-11 in the accurate diagnosis and survival rates of lymphoma and leukemia.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

It’s Never Too Late: Improve Clinical Trial Processes with a Unified Platform

Veeva

As scientific innovation has led to new trial designs, modern cloud technologies have enabled the industry to better manage how clinical trials are executed. Newer, more advanced cloud applications now offer unified data and process models, allowing organizations to manage their end-to-end clinical trial process within a single system. Rather than juggling individual point solutions, innovative organizations are using a unified clinical platform for greater efficiency, quality, and speed of execution. Join Veeva and Idorsia to learn how your organization can leverage a unified clinical operating model and drive new levels of efficiency across the entire clinical ecosystem.
Watch Now

CAR T cell metabolism and antitumor activity

Engineered T cells expressing high-affinity chimeric antigen receptors (CARs) confer remarkable tumor specificity by recognizing patient-specific tumor antigens and triggering antitumor activities.
Watch Now

Employing Innovative Platform Manufacturing and Biosafety Testing for your Gene Therapy Product to Reduce Time to Market

on24

As gene therapies and gene-modified cell therapies show increasing promise, the need for innovative and proficient viral vector manufacturing continues to grow. Concurrently, increased regulatory guidance governing the manufacturing and testing of viral vectors adds complexity and increases the timelines to successfully produce high-quality virus ready for clinical use.
Watch Now

Quantitative Cell Biology

In this webinar, you will learn about cutting-edge research and new methods in the field of quantitative cell biology. Specific topics to be covered include: “Cell painting predicts impact of lung cancer variants”;
Watch Now

Spotlight

resources